Holen Sie sich die Stockscreener-App
25.88
10.27%
2.41
Vorhandelsmarkt:
27.41
1.53
+5.91%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health (HIMS) Stock Up 7% Premarket Thursday, On Track for Best Week Ever - CoinCentral
Trending tickers: Nebius Group, Hims & Hers, BMW, Savills and On The Beach - Yahoo Finance UK
Hims & Hers (HIMS) soars 10.3% on analyst upgrades, new deal - MSN
Hims & Hers revamps GLP-1 strategy with Novo Nordisk - TipRanks
JPMorgan Chase & Co. Significantly Reduces Stake in Hims & Hers Health Inc. - GuruFocus
Hims & Hers (HIMS) Soars 10.3% on Analyst Upgrades, New Deal - Insider Monkey
A Look At Novo Nordisk’s Valuation After Hims & Hers GLP 1 Distribution Agreement - simplywall.st
Lucid Tops The Most-Shorted Stock List—Here Are 9 More Short Targets - Benzinga
Hims & Hers Hires Ex-Eli Lilly Communications Chief Amid Obesity Drug Strategy Shift - GuruFocus
Hims & Hers Stock Skyrockets as Landmark Settlement with Novo Nordisk Ends Weight-Loss Drug War - FinancialContent
Hims & Hers C-suite shake-up, Stryker outage may be Iran-backed - Yahoo Finance
HIMS Stock Jumps 14% – Barclays Says Market Is Underestimating Opportunity From New Products - Stocktwits
3 Big Reasons to Love Hims & Hers Health (HIMS) - Yahoo Finance
HIMS Jumps 14.5% Following Strong Market Interest - GuruFocus
Hims & Hers: The Novo Nordisk Deal Changes Everything (NYSE:HIMS) - Seeking Alpha
Hims & Hers Brings In Lilly Communications Veteran - GuruFocus
Hims & Hers Health (NYSE:HIMS) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
Barclays Raises Price Target for HIMS: Maintains Overweight Rati - GuruFocus
Hims & Hers Health Stock Is Surging Wednesday: What's Going On? - Benzinga
Hims & Hers Health (NYSE:HIMS) Shares Up 11.5% After Analyst Upgrade - MarketBeat
This Novo Nordisk Partnership Shows That HIMS Has All The Leverage (NYSE:HIMS) - Seeking Alpha
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Can Novo Nordisk's Hims & Hers Deal Revive Its GLP-1 Momentum? - Yahoo! Finance Canada
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk - Stocktwits
Hims And Hers Taps Veteran Communicator To Shape GLP 1 Growth Story - simplywall.st
Hims & Hers Health, Inc. (NYSE:HIMS) Given Consensus Rating of "Hold" by Analysts - MarketBeat
HIMS Stock Just Exploded — But the Real Story Might Be the Novo Nordisk Deal - TS Avisen
Hims & Hers appoints Kathryn Beiser as communications chief - Investing.com
Hims & Hers Names Kathryn Beiser as Chief Communications Officer - Business Wire
Hims Hires Ex-Lilly PR Chief as Its Weight-Loss Strategy Shifts - Bloomberg.com
Hims & Hers Expands Health Platform with Major Novo Nordisk Deal - StocksToTrade
Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track (NYSE:HIMS) - Seeking Alpha
Asset Manager Exits Shares of Hims & Hers Health - Yahoo Finance
What's Driving Attention Behind These Trending Stocks? MRVL, STRL, HIMS - Finviz
Hims & Hers Health Soars with Novo Nordisk Partnership Plans - timothysykes.com
Hims & Hers Stock Upgraded After Novo Nordisk Agreement. Why It Isn’t a Buy Yet. - Barron's
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal - MarketBeat
Hims and Hers Expands Consumer-Focused Digital Health Platform - Yahoo Finance
What's Fueling The Rise In Hims & Hers Health Stock Today? - Benzinga
Hims & Hers upgraded to Buy from Hold at Needham - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026 - FinancialContent
Hims & Hers Health (NYSE:HIMS) Upgraded at Citigroup - MarketBeat
Novo Nordisk and Hims & Hers Partner to Expand Semaglutide Access - Pharmaceutical Commerce
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers - HIMS Investor Relations
With Hims & Hers Benefits, holistic health starts here - Hims & Hers Newsroom
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price - MarketBeat
Hims & Hers Health (NYSE:HIMS) Raised to "Neutral" at Bank of America - MarketBeat
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More - 24/7 Wall St.
Novo and Hims & Hers become partners to end legal feud - Yahoo Finance
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock - Stocktwits
Trending Tickers Today: Hims & Hers, BlackRock, Shell, and GSK Draw Investor Attention - Meyka
Novo Nordisk and Hims & Hers are friends again - Morning Brew
Hims & Hers Soars 41% as Peace Pact with Novo Nordisk Unlocks Branded Wegovy and Ozempic - FXLeaders
Hims & Hers Burns $546M In Short Bets After Novo Nordisk Deal Sends Stock Soaring To Best Day Ever - Stocktwits
Needham upgrades Hims & Hers (HIMS) to Buy on March 9, 2026 - Meyka
Weight-Loss Truce: Hims & Hers Wins Novo Nordisk Deal, Soars 40% - NAI500
A Look At Hims & Hers Health (HIMS) Valuation After Novo Nordisk GLP 1 Partnership And Legal Truce - Yahoo Finance
Hims & Hers, Roku, Oracle, Autozi And Joby Aviation: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal - AOL.com
Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together - Law360
HIMS Surges as Citi Upgrades on Novo Nordisk Deal - GuruFocus
Hims & Hers: Not Selling Yet (NYSE:HIMS) - Seeking Alpha
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s - The Hill
HIMS Surges Over 40% After Partnership with Novo Nordisk - GuruFocus
Hims & Hers Health boosted at Citi on Novo Nordisk partnership - Seeking Alpha
AI for investors - MLQ.ai
0.93%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):